Adenosine A.sub.3 receptor modulators
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 14, 2008
Grant Date -
Aug 10, 2006
app pub date -
Jan 31, 2006
filing date -
Feb 2, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A class of novel antagonists for the adenosine A.sub.3 receptor are disclosed. These compounds are useful as therapeutic agents for a number of diseases and medical conditions that are mediated by the A.sub.3 receptor. The compounds of this invention are also useful as diagnostic agents for the A.sub.3 receptor.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully